Information regarding 2024 to be announced soon! Check back for updates

Breast cancer is the most common cancer affecting women. Diagnosis and treatments are part of the practice of a wide number of medical specialists and there are national initiatives calling for a multidisciplinary approach to the care of breast cancer patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important due to of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient.

The symposium will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery, and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction.  It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.

This three-day symposium will evaluate and discuss different models for coordination of breast cancer care from major centers across the United States. The  intent of this symposium is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols for the local treatment of breast cancer.

Participating in the three-day symposium will give you access to:

  • Three days’ worth of educational material with lectures given by expert faculty, interactive question and discussion sessions, and cadaver lab
  • Abstract poster presentations
  • Multiple symposia
  • Agenda includes Master’s Class in Markings and Decision Making: Innovations in Surgical Oncology

Course Directors:

Lucy De La Cruz, MD

Lucy De La Cruz, MD

MedStar Georgetown University Hospital
Washington, D.C.

Kenneth L. Fan, MD

Kenneth L. Fan, MD

MedStar Health Research Institute
MedStar Georgetown University Hospital
Georgetown University School of Medicine
Washington, D.C.

Ian T. Greenwalt, MD

Ian T. Greenwalt, MD

MedStar Georgetown University Hospital
Georgetown University School of Medicine
Washington, D.C.

David H. Song, MD, MBA, FACS

David H. Song, MD, MBA, FACS

MedStar Health
Washington, D.C.